← All stocks

Stoke Therapeutics, Inc.

STOK Net selling
CIK 0001623526 #2049 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$11.09M
$8.34M on a plan · $1.22M straight out of an exercise
Sold at will
$1.52M
33 of 85 sales
Net
−$11.09M
−$1.52M against sales at will

By person

9 insiders · 85 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Krainer Adrian R.
Director
$3.90M (5) scheduled
−$3.90M
283,302
0.4390%
$8.80M
−30.0%
Kaye Edward M. MD
Director
$3.18M (16) scheduled
−$3.18M
124,557
0.1930%
$3.87M
+365.6%
Ticho Barry
CHIEF MEDICAL OFFICER
$1.98M (30) scheduled
−$1.98M
20,110
0.0312%
$624.55K
+709.3%
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$1.56M (22) scheduled
−$1.56M
21,225
0.0329%
$659.18K
+167.4%
TZIANABOS ARTHUR
Director
$174.21K (1) scheduled
−$174.21K
31,339
0.0486%
$973.29K
−1.3%
Leggett Thomas
Chief Financial Officer
$147.14K (5)
−$147.14K
10,172
0.0158%
$315.91K
Hoitt Jason
Chief Patient Officer
$119.31K (5)
−$119.31K
10,276
0.0159%
$319.14K
+157.7%
LEVIN ARTHUR A
Director
$22.26K (1) scheduled
−$22.26K
4,237
0.0066%
$131.59K
Skorpios Trust entity
10% owner
3,906,181
6.05%
$121.31M
−64.0%
Insider
Date
Role
Action
Shares
Price
Amount
Ticho Barry
19 Mar 2026
CHIEF MEDICAL OFFICER
Sold after exercise
1,461
$29.99
$43.82K
TZIANABOS ARTHUR
10 Mar 2026
Interim Executive Chair
Sold after exercise
4,355
$40.00
$174.21K
Kaye Edward M. MD
8 Oct 2025
Director
Sold after exercise
25,000
$30.00
$750.00K
Allan Jonathan
3 Oct 2025
GENERAL COUNSEL & CORP SEC
Sold after exercise
10,000
$25.07
$250.65K

What was left out

Form 4 filings counted 57
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 48
Sales straight out of an exercise 4
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 297,405
History held since 20 Jun 2019